- Pfizer and Moderna set to adapt to Omicron COVID variant New York Post
- Pfizer/BioNTech seeking data on new COVID variant Reuters
- Pfizer said an updated version of its COVID-19 vaccine will be 'ready in 100 days' if the new Omicron variant is resistant to its current vaccine Yahoo! Voices
- Moderna, BioNTech among weekly healthcare gainers amid fears over new COVID-19 variant Seeking Alpha
- Merck says its Covid antiviral treatment less effective than first thought Financial Times
- View Full Coverage on Google News
from Top stories - Google News https://ift.tt/3nXA0ri
No comments:
Post a Comment